Nuvo Research Inc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DaveAu who wrote (5953)	11/29/2000 12:32:30 AM
From: Joe Krupa	Read Replies (2) of 14101

Hi Dave, "It's also sounding like they're not trying to go head to head with the oral NSAIDS, at least initially. They're targeting the other topicals and the people with kidney and G.I. problems." Could this possibly be good politicking by Dimethaid, until all approvals are in, particularly the FDA? I think we have all been made keenly aware lately (read HPB) that good politics is an essential tactic in seeking regulatory approval. An all out PR/marketing assault on the oral NSAID market might not sit well with the egos that be at Celebrex or Vioxx. It could possibly intensify political pressure against Pennsaid in other countries who have not yet approved. Dimethaid knows Pennsaid will eventually take a chunk out of the oral NSAID market, so why rub it in their faces (no pun intended) off the get go? Why risk it? I say, let's be the well behaved new kid on the block until we are in a better position to unleash the full PR machine. Just some late night thoughts. Joe

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next